Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Dosing protocols are based on clinical research, pharmacokinetic data, and community experience with the peptide
These factors contribute to better reproducibility in research and reduced variability in results
Most research-supply guidance keeps reconstituted vials usable for about 3-4 weeks
AOD-9604 is a synthetic copy of that region, plus one extra amino acid for stability
Long-Term Safety Evidence While many peptide therapies have been evaluated only in short-term trials, AOD-9604 benefits from long-term safety data extending to 24 weeks of continuous administration
The flexibility of these preparations lets doctors adjust the dose as needed
